-
Sleeping Aids Market Segments, Drivers, Restraints, And Trends For 2024-2033
03 Oct 2024 18:14 GMT
… & Johnson Services Inc., Mylan N.V., BMC Medical Co … and sporadic sleeplessness. Sleeping aids can help decrease daytime … of the global sleeping aids market report covering trends, … aids market size, sleeping aids market drivers and trends, sleeping aids …
-
Human medicines European public assessment report (EPAR): Darunavir Viatris (previously Darunavir Mylan), darunavir, Date of authorisation: 03/01/2017, Revision: 17, Status: Authorised
23 Aug 2024 09:07 GMT
The active substance in Darunavir Viatris, darunavir, is a protease inhibitor. It blocks protease, an enzyme involved in the reproduction of HIV. When the enzyme is blocked, the virus does not reproduce normally, slowing down its multiplication in the body …
-
Benefit concert aids early detection efforts at WVU Cancer Institute held in memory of late music lover
24 Jul 2024 02:20 GMT
Mountain State native Tonie Renner Gentile had a lifelong passion for music that endured through her brief battle with breast cancer.
Following her death at 52, her family is celebrating her memory with a Morgantown benefit concert that will aid early …
-
Human medicines European public assessment report (EPAR): Lopinavir/Ritonavir Viatris (previously Ritonavir Mylan), lopinavir,ritonavir, Date of authorisation: 14/01/2016, Revision: 20, Status: Authorised
22 Jul 2024 12:48 GMT
The active substances in this medicine, lopinavir and ritonavir, are protease inhibitors: they block an enzyme called protease that is involved in the replication of HIV. When the enzyme is blocked, the virus does not replicate normally, slowing down the …
-
Human medicines European public assessment report (EPAR): Tenofovir disoproxil Mylan, tenofovir disoproxil, Date of authorisation: 08/12/2016, Revision: 19, Status: Authorised
19 Jul 2024 08:05 GMT
… has infected. Tenofovir disoproxil Mylan, taken in combination with … disoproxil Mylan does not cure HIV infection or AIDS, but … and diseases associated with AIDS.
Tenofovir also interferes with … viral DNA. Tenofovir disoproxil Mylan stops the virus making …
-
India Immuno Oncology Drugs Market Size, Growth Opportunities, Current Trends, Forecast 2031| AstraZeneca plc, Mylan N.V
18 Jul 2024 06:37 GMT
… .
◘ Intas Pharmaceuticals Ltd.
◘ AstraZeneca plc
◘ Mylan N.V.
◘ Dr. Reddy… Research Expertise: Coherent Market Insights aids businesses in comprehending their target …
-
U.S. Naloxone Market Set to Experience Significant Growth by 2031: Mylan N.V., Novartis AG, Indivior Plc., ADAPT Pharma
22 Mar 2024 09:51 GMT
… in U.S. Naloxone Market:
◘ Mylan N.V.
◘ Novartis AG
◘ Indivior … Research Expertise: Coherent Market Insights aids businesses in comprehending their target …
-
Insights on the HIV/AIDS Diagnostics Global Market to 2030 - Featuring Abbott Laboratories, Abbvie, Alere, Apogee Flow Systems and Beckman Coulter Among Others
30 Jan 2023 22:15 GMT
… , awareness about HIV/AIDs diagnosis and treatment, rising research … driving the HIV/AIDS diagnostic market.
Along with … Summary
3. HIV/AIDS Diagnostics Market: Competitive Analysis
3 … . Strategic Initiatives
11.17. Mylan Inc
11.17.1. Company …
-
Worldwide HIV/AIDS Diagnostics Industry to 2030 - Rapid Tests and ELISA Form the Major Markets for the HIV Diagnostic Tests - ResearchAndMarkets.com
30 Jan 2023 15:31 GMT
… .
Merch & Co. Inc
Mylan Inc
Janssen Therapeutics
According to … , awareness about HIV/AIDs diagnosis and treatment, rising research … driving the HIV/AIDS diagnostic market.
Along with … programs laid for treatment of AIDS, which further drives the …
-
Corporate Reputation of the Pharma Industry 2021-2022: The Views of 168 HIV/AIDS Patient Groups - ResearchAndMarkets.com
16 Dec 2022 09:45 GMT
… according to respondent HIV/AIDS patient groups, as follows:
… :
Executive summary
HIV/AIDS patient-group relationships with pharma … its respondent HIV/AIDS patient group partners,.
Company … & Co/MSD
Mylan
Roche/Genentech
Sandoz
Sanofi …
About
© 1995-2025